Home LiteratureArticle Details
PMID: 6025120 Published · ppublish English Journal Article

Leukemogenic activity of ether-extracted Rauscher leukemia virus.

Science (New York, N.Y.) ·Vol. 156 ·No. 3782 ·1967-06-23 ·Pages 1610-3

Shibley GP, Durr FE, Schidlovsky G, Wright BS, Schmitter R

Abstract

After rapid multiple extractions of mouse plasma virus with ether, the aqueous solution contained viral nucleoids that were infectious when inoculated intracranially into newborn BALB/c mice. The infectivity associated with the ether extract was not neutralized by the specific antibody prepared against the whole virus. No intact virus has been seen in these preparations. Treatment with ether completely removed the virus envelope from the particle and produced an apparently homogeneous preparation of viral nucleoids. After the extractions with ether, leukemogenic activity was inactivated by exposure to ribonuclease. The leukemogenic activity of the many-passaged Rauscher virus that has been propagated in tissue culture and that has low infectivity was also retained, and, in two experiments in which material was inoculated intracranially into mice, this activity appeared to have been enhanced by multiple extractions with ether.

MeSH Terms
Animals Animals, Newborn Culture Techniques Ethers Mice Microscopy, Electron Neutralization Tests Rauscher Virus/immunology,pathogenicity Ribonucleases Virulence
Chemicals
Ethers Ribonucleases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Shibley G P
Durr F E
Schidlovsky G
Wright B S
Schmitter R
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1967-06-23
Pages
1610-3
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com